Doctors at Haifa’s Rambam Medical Center for the first time implanted a new Israeli device that treats heart failure.
According to a statement from Rambam, the trial implanted the device into the heart of a man suffering from diastolic heart failure, who volunteered for the procedure after hearing about from his doctor.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
Robert MacLachlan, 72 from Canada, asked to have the CORolla device implanted into his heart after hearing about it from his cardiologist.
Diastolic heart failure occurs when the heart is unable to pump sufficiently to maintain blood flow to meet the body’s needs. Signs and symptoms commonly include shortness of breath, excessive fatigue, leg swelling and lack of stamina to perform exercise or even simple physical tasks. Forty percent of patients diagnosed with the condition die within five years. Symptoms include shortness of breath, fatigue, swollen legs, and the lack of stamina to perform exercise or even simple physical tasks.
The CORolla device, developed by Israeli company CorAssist Cardiovascular, is a spring-like mechanism made of metal wire that includes a set of springs that work together to push outward after being compressed by the left ventricle. The push against the walls of the left ventricle opens up to a greater volume, allowing it to fill with blood.
The CorAssist technology was invented by Dr. Yair Feld, a cardiologist at Rambam Health Care Campus, together with Dr. Yotam Reisner and Dr. Shay Dubi.
According to Professor Gil Bolotin, who heads the cardiac surgery department at Rambam and co-led the team that implanted the device, there are several patients interested in having the device implanted.
Israel’s Health Ministry has approved up to ten trials of the CORolla implant.
